Zimmer Biomet touts 7-year results in Mobi-C cervical disc trial

This study further validates the strengths of Mobi-C as a solution for cervical total disc replacement. The positive clinical outcomes remain consistent with previous findings, mainly that Mobi-C continues to deliver positive patient outcomes including efficacy, safety, patient satisfaction and fewer follow-up surgeries. It is particularly important that the clinical effectiveness of cTDR versus ACDF becomes more apparent when treatment increases from one to two levels, indicating a significant benefit for Mobi-C in two-level procedures, which affects an estimated one in three cervical disc patients,” Zimmer Biomet spine division GM Joe Ross said in a press release. Earlier this week, Zimmer Biomet said it will participate in the US Dept. of Energy’s Better Buildings, Better Plants energy reduction programs as it looks to reduce its carbon footprint in the US and Puerto Rico. The post Zimmer Biomet touts 7-year results in Mobi-C cervical disc trial appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Spinal zimmerbiomet Source Type: news